tiprankstipranks
Advertisement
Advertisement
Fresenius Medical Care: Sell Rating Reiterated as Growth Concerns Persist and $32 Price Target Remains Unchanged
PremiumRatingsFresenius Medical Care: Sell Rating Reiterated as Growth Concerns Persist and $32 Price Target Remains Unchanged
8d ago
Fresenius Medical Care Refines Segment Reporting and Affirms Controls in Latest Form 6-K
Premium
Company Announcements
Fresenius Medical Care Refines Segment Reporting and Affirms Controls in Latest Form 6-K
8d ago
Fresenius Medical Care Beats Q2 2026 Expectations and Reaffirms Full-Year Outlook
Premium
Company Announcements
Fresenius Medical Care Beats Q2 2026 Expectations and Reaffirms Full-Year Outlook
9d ago
Fresenius Medical downgraded to Underperform from Neutral at BNP Paribas
PremiumThe FlyFresenius Medical downgraded to Underperform from Neutral at BNP Paribas
15d ago
Sell Rating Reiterated on Deteriorating Fundamentals, Earnings Headwinds and Unchanged $32 Price Target
Premium
Ratings
Sell Rating Reiterated on Deteriorating Fundamentals, Earnings Headwinds and Unchanged $32 Price Target
23d ago
Fresenius Medical price target raised to EUR 41 from EUR 40 at Citi
Premium
The Fly
Fresenius Medical price target raised to EUR 41 from EUR 40 at Citi
26d ago
Fresenius Medical launches first tranche of share buyback program
PremiumThe FlyFresenius Medical launches first tranche of share buyback program
3M ago
Fresenius Medical Care AGM Backs Higher Dividend, New Buyback Mandate and U.S. Rollout of 5008X System
Premium
Company Announcements
Fresenius Medical Care AGM Backs Higher Dividend, New Buyback Mandate and U.S. Rollout of 5008X System
3M ago
Fresenius Medical announces EUR 1B share buyback program
Premium
The Fly
Fresenius Medical announces EUR 1B share buyback program
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100